Department of Urology, Augusta University, USA
*Corresponding author: Martha K Terris, Department of Urology, Medical College of Georgia, Augusta University, Augusta, GA, USA
Submission: January 31, 2018; Published: February 12, 2018
ISSN: 2578-0395 Volume1 Issue4
Since its initial description by Brunschwig in 1948 , pelvic exenteration has become an established procedure to treat locally advanced or recurrent gastrointestinal, gynecologic and urologic malignancies as well as after failure of other options for radiation cystitis/colitis and neurogenic bladder/bowel. This procedure typically involves en bloc removal of the remaining pelvic viscera: bladder, rectum, and prostate/seminal vesicles in males or uterus and vagina (partial or complete) in females . Given the extensive resection and reconstruction involved, frequent prior radiation, and prevalence of adhesions from multiple prior procedures, perioperative complications are commonly encountered [3,4].